Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 17, 2025 08:32 ET | Source: Research and Markets

$56.09 Bn IVF Services Global Market Opportunities and Strategies to 2034: Top 10 Players Hold 7.9% of 2023 Market, Led by IVIRMA Global with 2.63% Share

Dublin, Nov. 17, 2025 (GLOBE NEWSWIRE) -- The "IVF Services Global Market Opportunities And Strategies To 2034" report has been added to ResearchAndMarkets.com's offering. This report describes...
September 23, 2025 05:12 ET | Source: Research and Markets

U.S. Menopause Market Size, Share & Trends Analysis Report 2025-2033: Competitive Analysis of Pfizer, Novo Nordisk, TherapeuticsMD, Bayer, AbbVie, Pure Encapsulations, PADAGIS

Dublin, Sept. 23, 2025 (GLOBE NEWSWIRE) -- The "U.S. Menopause Market Size, Share & Trends Analysis Report by Type (Hormonal, Non-Hormonal, and Dietary Supplements), by Country (West, South,...
April 03, 2025 04:02 ET | Source: Research and Markets

Advanced Recurrent Ovarian Cancer Market Research 2025-2032: Advancements in Biomarker Research, Development of Personalised & Combination Therapies, Growing Pharmaceutical/Institutions Collaborations

Dublin, April 03, 2025 (GLOBE NEWSWIRE) -- The "Advanced Recurrent Ovarian Cancer Market" report has been added to ResearchAndMarkets.com's offering.The advanced recurrent ovarian cancer market was...
January 27, 2025 07:34 ET | Source: M42

M42’s Danat Al Emarat Hospital for Women & Children partners with ProFaM to offer revolutionary reproductive health services

Danat Al Emarat Hospital partners with ProFaM to perform ovarian tissue cryopreservation, offering solutions for women looking to preserve their fertility.
January 23, 2025 06:00 ET | Source: Research and Markets

Ovarian Cancer Market Research 2024: Creation of Novel Biomarkers and Genetic Testing Gaining Pace - Global $31.3 Billion Market Forecasts to 2034

Dublin, Jan. 23, 2025 (GLOBE NEWSWIRE) -- The "Ovarian Cancer Market by Type, by Diagnosis Scans, by Treatment, by End-user, and by Region" report has been added to ResearchAndMarkets.com's...
July 10, 2024 04:06 ET | Source: Research and Markets

United States Ovarian Cancer Diagnostics Market Witnesses Notable Growth, Expected to Propel at a CAGR of 5.79% Through 2029 - Advancements in Imaging and Genetic Testing as Major Growth Drivers

Dublin, July 10, 2024 (GLOBE NEWSWIRE) -- The "United States Ovarian Cancer Diagnostics Market, By Region, Competition, Forecast and & Opportunities, 2019-2029F" report has been added to ...
June 10, 2024 10:11 ET | Source: Research and Markets

Ovarian Cancer Pipeline Drugs Analysis, 2024: Insights on 180+ Companies and 200+ Pipeline Drugs, Including Atezolizumab (Genentech), Tisotuma Vedotin (Genmab), and SON-1010 (Sonnet Biotherapeutics)

Dublin, June 10, 2024 (GLOBE NEWSWIRE) -- The "Ovarian Cancer - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This report provides comprehensive...
May 17, 2024 09:25 ET | Source: Research and Markets

Polycystic Ovary Syndrome (PCOS) Treatment Global Strategic Research Report 2024-2030: North America and Europe Dominates, Asia-Pacific to Exhibit Fastest Growth

Dublin, May 17, 2024 (GLOBE NEWSWIRE) -- The "Polycystic Ovary Syndrome (PCOS) Treatment - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.Global...
April 09, 2024 10:50 ET | Source: Research and Markets

Polycystic Ovarian Syndrome (PCOS) Competitive Landscape Report 2024: Out of 18 Drugs in the Pipeline for PCOS, Only 3 have Reached the Phase III Stage of Development

Dublin, April 09, 2024 (GLOBE NEWSWIRE) -- The "Polycystic Ovarian Syndrome (PCOS) - Competitive Landscape" report has been added to ResearchAndMarkets.com's offering. This report presents a...
April 09, 2024 07:02 ET | Source: Research and Markets

Ovarian Cancer Opportunity Assessment Report 2024: A Blockbuster Market that is Expected to Grow from $3.3 Billion in 2022 to $4.1 Billion in 2032 with ImmunoGen, AstraZeneca, Merck, & GSK Dominating

Dublin, April 09, 2024 (GLOBE NEWSWIRE) -- The "Ovarian Cancer Opportunity Assessment and Forecast" report has been added to ResearchAndMarkets.com's offering.Ovarian Cancer is one of the most...